Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.
This report contains market size and forecasts of Rheumatoid Arthritis Testing in Global, including the following market information:
Global Rheumatoid Arthritis Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rheumatoid Arthritis Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serological Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Testing include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthcare GmbH, Imaware, Augurex Life Sciences, Qiagen, Svar Life Science AB and Exagen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatoid Arthritis Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rheumatoid Arthritis Testing Market Segment Percentages, by Type, 2021 (%)
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Global Rheumatoid Arthritis Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rheumatoid Arthritis Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Diagnostic Centers
Others
Global Rheumatoid Arthritis Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rheumatoid Arthritis Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rheumatoid Arthritis Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthcare GmbH
Imaware
Augurex Life Sciences
Qiagen
Svar Life Science AB
Exagen
Aviva Systems Biology
Bio-Rad Laboratories